DE60104110D1 - Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit - Google Patents

Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit

Info

Publication number
DE60104110D1
DE60104110D1 DE60104110T DE60104110T DE60104110D1 DE 60104110 D1 DE60104110 D1 DE 60104110D1 DE 60104110 T DE60104110 T DE 60104110T DE 60104110 T DE60104110 T DE 60104110T DE 60104110 D1 DE60104110 D1 DE 60104110D1
Authority
DE
Germany
Prior art keywords
parkinson
disease
benzoxazine
treatment
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60104110T
Other languages
English (en)
Other versions
DE60104110T2 (de
Inventor
Elizabeth Augelli-Szafran
Thomas Boehme
Douville Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE60104110D1 publication Critical patent/DE60104110D1/de
Application granted granted Critical
Publication of DE60104110T2 publication Critical patent/DE60104110T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60104110T 2000-05-09 2001-04-17 Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit Expired - Fee Related DE60104110T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20278700P 2000-05-09 2000-05-09
US202787P 2000-05-09
PCT/US2001/012528 WO2001085734A1 (en) 2000-05-09 2001-04-17 Benzoxazines for use in the treatment of parkinson's disease

Publications (2)

Publication Number Publication Date
DE60104110D1 true DE60104110D1 (de) 2004-08-05
DE60104110T2 DE60104110T2 (de) 2005-08-25

Family

ID=22751255

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60104110T Expired - Fee Related DE60104110T2 (de) 2000-05-09 2001-04-17 Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit

Country Status (13)

Country Link
US (1) US6812228B2 (de)
EP (1) EP1282625B1 (de)
JP (1) JP2003532733A (de)
AT (1) ATE270295T1 (de)
AU (1) AU2001251662A1 (de)
BR (1) BR0110643A (de)
CA (1) CA2407789A1 (de)
DE (1) DE60104110T2 (de)
DK (1) DK1282625T3 (de)
ES (1) ES2223824T3 (de)
MX (1) MXPA02010270A (de)
PT (1) PT1282625E (de)
WO (1) WO2001085734A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112012002844T5 (de) 2011-07-05 2014-04-24 Electronic Scientific Industries, Inc. Verfahren zur Laserbearbeitung mit einem thermisch stabilisierten akustooptischen Strahlablenker und thermisch stabilisiertes Hochgeschwindigkeits-Laserbearbeitungssystem
US9463186B2 (en) 2013-04-15 2016-10-11 Northwestern University Treatment for dopaminergic disorders

Also Published As

Publication number Publication date
CA2407789A1 (en) 2001-11-15
MXPA02010270A (es) 2003-04-25
DK1282625T3 (da) 2004-11-15
US6812228B2 (en) 2004-11-02
PT1282625E (pt) 2004-10-29
BR0110643A (pt) 2003-03-18
US20030220335A1 (en) 2003-11-27
DE60104110T2 (de) 2005-08-25
WO2001085734A1 (en) 2001-11-15
AU2001251662A1 (en) 2001-11-20
ES2223824T3 (es) 2005-03-01
EP1282625A1 (de) 2003-02-12
JP2003532733A (ja) 2003-11-05
EP1282625B1 (de) 2004-06-30
ATE270295T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
JO2668B1 (en) Isoczazolins for controlling invertebrate insects
DE60220422D1 (de) Substituierte pyrazoloverbindungen zur behandlung von entzündungen
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
GB0318447D0 (en) Therapeutic agents
GB9524157D0 (en) Therapeutic agents
IL171977A0 (en) Cyclic sulfonamides for inhibition of gamma-secretase
SE0104332D0 (sv) Therapeutic agents
BG108207A (en) Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
ATE457988T1 (de) A2a-adenosin-rezeptor-antagonisten
MXPA05007115A (es) Nuevos agonistas inversos del receptor cb 1.
BRPI0418181A (pt) emprego de 2-aminotetralinas substituìdas para prevenção do tratamento de morbus parkinson
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
UY25143A1 (es) Procedimiento para la preparacion de inhibidores de proteasas.
NZ528997A (en) Sulfonamides
ES2097496T3 (es) Derivados acilaminoindol como agonistas de 5-ht1.
DE69713273D1 (de) Verwendung von 3,4-Diphenylchromanen zur Herstellung eines Arzneimittels zur Behandlung bzw. Vorbeugung des Prostatakarzinoms
PE20050254A1 (es) N-[3-(3-SUSTITUIDAS-PIRAZOLO [1,5-a]PIRIMIDIN-7-IL) FENIL]-SULFONAMIDAS Y COMPOSICIONES RELACIONADAS
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE270295T1 (de) Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit
DE60226971D1 (de) Corticotropinfreisetzungsfaktor antagonisten
ATE273978T1 (de) 7-aminopyrido(2,3-d)-pyrimidine derivate zur behandlung von bronchialasthma
TW200612912A (en) Benzyloxy derivatives as maob inhibitors
ES2193047T3 (es) (3,4 dihydro-2h-benzo(1,4) oxazinilmetil)(3-(1h-indol-3-il)-alquil)-aminas.
ATE250027T1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
HUP0301561A2 (hu) Triazintrion-szulfoxidok alkalmazása kokcidiózis elleni készítmények elżállítására

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee